Cargando…

Cytotoxic Effects of Fascaplysin against Small Cell Lung Cancer Cell Lines

Fascaplysin, the natural product of a marine sponge, exhibits anticancer activity against a broad range of tumor cells, presumably through interaction with DNA, and/or as a highly selective cyclin-dependent kinase 4 (CDK4) inhibitor. In this study, cytotoxic activity of fascaplysin against a panel o...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hamilton, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967216/ https://www.ncbi.nlm.nih.gov/pubmed/24608973 http://dx.doi.org/10.3390/md12031377

Ejemplares similares

Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2018)

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
por: Plangger, Adelina, et al.
Publicado: (2021)

Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK
por: Oh, Taek-In, et al.
Publicado: (2017)

Fascaplysin Induces Apoptosis and Ferroptosis, and Enhances Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) by Promoting PD-L1 Expression
por: Luo, Lianxiang, et al.
Publicado: (2022)

The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity
por: Ampofo, Emmanuel, et al.
Publicado: (2015)

Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines
por: Martinez-Torres, Ana Carolina, et al.
Publicado: (2019)

Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells
por: Plangger, Adelina, et al.
Publicado: (2021)

Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines
por: Hochmair, Maximilian, et al.
Publicado: (2019)

FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling
por: Shafiq, Muhammad Imtiaz, et al.
Publicado: (2012)

Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro
por: Bryukhovetskiy, Igor, et al.
Publicado: (2017)

Total Syntheses and Preliminary Biological Evaluation of Brominated Fascaplysin and Reticulatine Alkaloids and Their Analogues
por: Zhidkov, Maxim E., et al.
Publicado: (2019)

Marine-Derived Lead Fascaplysin: Pharmacological Activity, Total Synthesis, and Structural Modification
por: Wang, Chao, et al.
Publicado: (2023)

Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA
por: Oh, Taek-In, et al.
Publicado: (2017)

Synergism of Cyclin-Dependent Kinase Inhibitors with Camptothecin Derivatives in Small Cell Lung Cancer Cell Lines
por: Hamilton, Gerhard, et al.
Publicado: (2014)

Study of Structure–Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer Agents
por: Zhidkov, Maxim E., et al.
Publicado: (2022)

A New Mild Method for Synthesis of Marine Alkaloid Fascaplysin and Its Therapeutically Promising Derivatives
por: Tryapkin, Oleg A., et al.
Publicado: (2023)

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2019)

A pyrone remodeling strategy to access diverse heterocycles: application to the synthesis of fascaplysin natural products
por: Palani, Vignesh, et al.
Publicado: (2020)

Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation
por: Rath, Barbara, et al.
Publicado: (2023)

Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell lines
por: Plangger, Adelina, et al.
Publicado: (2022)

Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
por: Derbyshire, E. J., et al.
Publicado: (1992)

Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer
por: Rath, Barbara, et al.
Publicado: (2020)

In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell Lines
por: Klameth, Lukas, et al.
Publicado: (2017)

How to target small cell lung cancer
por: Hamilton, Gerhard, et al.
Publicado: (2015)

BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549
por: Franks, S. Elizabeth, et al.
Publicado: (2016)

Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines
por: Kroep, J R, et al.
Publicado: (2000)

Comparison of the Inhibitory Binding Modes Between the Planar Fascaplysin and Its Nonplanar Tetrahydro-β-carboline Analogs in CDK4
por: Liang, Yan, et al.
Publicado: (2021)

Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adenocarcinoma cells
por: Khaghanzadeh, Narges, et al.
Publicado: (2012)

Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
por: Jensen, P. B., et al.
Publicado: (1993)

Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines.
por: Zangemeister-Wittke, U., et al.
Publicado: (1998)

Co-Loaded Curcumin and Methotrexate Nanocapsules Enhance Cytotoxicity against Non-Small-Cell Lung Cancer Cells
por: Rudnik, Loanda Aparecida Cabral, et al.
Publicado: (2020)

Comparative characteristics of small cell lung cancer and Ewing’s sarcoma: a narrative review
por: Hamilton, Gerhard
Publicado: (2022)

The role of oxidative stress in 63 T-induced cytotoxicity against human lung cancer and normal lung fibroblast cell lines
por: Kucinska, Malgorzata, et al.
Publicado: (2018)

p53-independent structure-activity relationships of 3-ring mesogenic compounds’ activity as cytotoxic effects against human non-small cell lung cancer lines
por: Fukushi, Saori, et al.
Publicado: (2016)

Cytotoxic Effects of Nanoliposomal Cisplatin and Diallyl Disulfide on Breast Cancer and Lung Cancer Cell Lines
por: Gunasekaran, Kaavya, et al.
Publicado: (2023)

Combination of three cytotoxic agents in small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2012)

9-Methylfascaplysin Is a More Potent Aβ Aggregation Inhibitor than the Marine-Derived Alkaloid, Fascaplysin, and Produces Nanomolar Neuroprotective Effects in SH-SY5Y Cells
por: Sun, Qingmei, et al.
Publicado: (2019)

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
por: Liang, Yi-Hsin, et al.
Publicado: (2016)

Cytotoxicity of Sargassum angustifolium Partitions against Breast and Cervical Cancer Cell Lines
por: Vaseghi, Golnaz, et al.
Publicado: (2018)

In vitro cytotoxic potential of Solanum nigrum against human cancer cell lines
por: Nawaz, Aisha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7fjk000eb7uf6ti4t253jql2ra